PainChek Ltd
ASX:PCK

Watchlist Manager
PainChek Ltd Logo
PainChek Ltd
ASX:PCK
Watchlist
Price: 0.037 AUD Market Closed
Market Cap: 77m AUD
Section:
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one PCK stock under the Base Case scenario is 0.004 AUD. Compared to the current market price of 0.037 AUD, PainChek Ltd is Overvalued by 89%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PCK Relative Value
Base Case
0.004 AUD
Overvaluation 89%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

22.9
P/S
P/S
Price to Sales
22.9
vs History
87
vs Industry
7
Median 3Y
28.1
Median 5Y
40.8
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-8.8
Median 5Y
-10.9
Industry
22.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-11.4
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-11.4
Industry
21.3
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
2
Median 3Y
31.4
Median 5Y
14.7
Industry
2.2
More Details
22.4
EV/S
EV/S
Enterprise Value to Sales
22.4
vs History
85
vs Industry
7
Median 3Y
26.7
Median 5Y
39.2
Industry
2.5
More Details
75.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
75.6
vs History
41
vs Industry
4
Median 3Y
81.7
Median 5Y
68.9
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-8.5
Median 5Y
-10.1
Industry
11.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-8.5
Median 5Y
-10.1
Industry
16.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-11.1
Industry
14.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-11.1
Industry
18.3
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
0
Median 3Y
-40.3
Median 5Y
-35.4
Industry
1.8
More Details

Multiples Across Competitors

PCK Competitors Multiples
PainChek Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
PainChek Ltd
ASX:PCK
77m AUD 22.9 -10 -9.8 -9.8
US
Veeva Systems Inc
NYSE:VEEV
39.5B USD 13 46.5 35.9 37.5
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
27.2B AUD 123.2 235.7 163.1 163.1
JP
M3 Inc
TSE:2413
1.8T JPY 5.8 43.6 22.2 26.5
US
Doximity Inc
NYSE:DOCS
9.6B USD 15.3 37.5 33.3 34.9
US
Waystar Holding Corp
NASDAQ:WAY
6.3B USD 6 56.1 18.5 28.9
SE
Sectra AB
STO:SECT B
54.3B SEK 25.4 92.7 -131.4 -131.4
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
287.8B INR 10.1 55.3 34.5 40.2
US
Vocera Communications Inc
F:V00
2.4B EUR 11.8 -325.1 265.4 4 249.5
US
Inspire Medical Systems Inc
NYSE:INSP
3.3B USD 3.7 58.6 46.4 62.3
P/E Multiple
Earnings Growth PEG
AU
PainChek Ltd
ASX:PCK
Average P/E: 75.5
Negative Multiple: -10 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
46.5
32%
1.5
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
235.7
33%
7.1
JP
M3 Inc
TSE:2413
43.6
15%
2.9
US
Doximity Inc
NYSE:DOCS
37.5
18%
2.1
US
W
Waystar Holding Corp
NASDAQ:WAY
56.1
N/A N/A
SE
Sectra AB
STO:SECT B
92.7
14%
6.6
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
55.3
30%
1.8
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -325.1 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
58.6
15%
3.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
PainChek Ltd
ASX:PCK
Average EV/EBITDA: 71.2
Negative Multiple: -9.8 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
35.9
38%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
163.1
32%
5.1
JP
M3 Inc
TSE:2413
22.2
13%
1.7
US
Doximity Inc
NYSE:DOCS
33.3
23%
1.4
US
W
Waystar Holding Corp
NASDAQ:WAY
18.5
19%
1
SE
Sectra AB
STO:SECT B
Negative Multiple: -131.4 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
34.5
24%
1.4
US
V
Vocera Communications Inc
F:V00
265.4
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
46.4
88%
0.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
PainChek Ltd
ASX:PCK
Average EV/EBIT: 520.7
Negative Multiple: -9.8 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
37.5
39%
1
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
163.1
31%
5.3
JP
M3 Inc
TSE:2413
26.5
N/A N/A
US
Doximity Inc
NYSE:DOCS
34.9
24%
1.5
US
W
Waystar Holding Corp
NASDAQ:WAY
28.9
49%
0.6
SE
Sectra AB
STO:SECT B
Negative Multiple: -131.4 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
40.2
28%
1.4
US
V
Vocera Communications Inc
F:V00
4 249.5
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
62.3
32%
1.9

See Also

Summary
PCK intrinsic value, competitors valuation, and company profile.
DCF Valuation
PCK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PCK stock valuation using valuation multiples.
Wall Street Estimates
PCK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PCK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 298,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.